This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Best Leveraged ETFs of First Half of 2017
by Sanghamitra Saha
Inside the top five leveraged ETFs of the first half of 2017.
5 Reasons Why Biotech ETFs are Soaring
by Sanghamitra Saha
Reasons that propelled the biotech space and the related ETFs higher.
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
by Sanghamitra Saha
Clovis Oncology clinical trial data has given a boost to the biotech sector and put these stocks and ETFs in focus.
7 Best Leveraged ETFs So Far in 2017
by Sweta Killa
Amid bouts of volatility, global stocks hit all-time highs on hopes of reflation trade and a slew of robust global data on export, employment and inflation.
Leveraged ETFs: How Are They Built and What's Hot Now?
by Eric Dutram
Do you know how leveraged and inverse ETFs work? Find out in this edition of the Dutram Report, where we discuss that topic, and some of the hottest funds in the leveraged and inverse ETF world right now.
How to Invest in Leveraged Biotechnology ETFs
by Eric Dutram
What investors need to know about leveraged and inverse biotechnology ETF investing.
Bull Market Here to Stay: 10 ETF Ways to Play
by Sweta Killa
The bull trend in the stocks will likely to continue in the coming months assuming that the Trump rally will stretch and seasonality boom.
10 Leveraged/Inverse ETFs with Over 30% Surge in November
by Sweta Killa
Inside the best performing Leveraged/Inverse ETFs of November.